Cognitive decline in aging and AD: neuroprotection by hypermyelination in FusOLcKO
Cognitive decline in aging and AD: neuroprotection by hypermyelination in FusOLcKO
批准号:
10369130
负责人:
FRANCA CAMBI
金额:
$15.41万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-15 至 2023-12-31
关键词:
AdultAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAxonBehaviorBehavioralBrainCaliberCell DensityCellsCholesterolCognitiveCommunitiesDNA-Binding ProteinsDataDiseaseElectrophysiology (science)Energy MetabolismEnzymesExploratory BehaviorFailureFutureGenetic TranscriptionGlutamatesHealthHippocampal FormationHippocampus (Brain)HistologicHumanImmunohistochemistryImpaired cognitionLearningLifeMaintenanceMeasuresMemoryMemory LossMetabolic stressMusMyelinNerve DegenerationNeuronsNeurophysiology - biologic functionNuclear RNAOligodendrogliaPathologyPhenotypePhosphorylationPlayRNA ProcessingRNA SplicingResourcesRoleSignal TransductionStandardizationStructureSynapsesTestingThickage relatedagedbrain computer interfacecell typecholesterol biosynthesisdensityfused in sarcomaimaging studyimplantationimprovedin vivomemory consolidationmemory encodingmotor behaviormouse modelmyelinationneural circuitneural networkneuronal survivalneuroprotectionnovelnovel strategiesprotective effectrelating to nervous systemresponsespatial memorysynaptogenesistranscriptome sequencingvisual learningwhite matterwhite matter changeyoung adult
中文摘要
该R 03应用旨在大大提高对少突胶质细胞和髓鞘支持的理解,
在衰老和阿尔茨海默病(AD)/AD中维持轴突完整性、突触和神经网络功能
相关痴呆(RD)。几条证据支持白色物质和OL损失在AD中的早期作用。
人类成像研究显示AD在明显认知下降和RNA Seq研究之前的白色物质变化
表明OL可能是最受影响的细胞类型,特别是在病程的早期。
AD.利用OL和髓鞘在AD/ADRD中的神经保护作用代表了一种阻止AD/ADRD的新策略。
在AD/ADRD过程的早期神经变性。我们计划利用我们的新的髓鞘增生FusOLcKO
运动和探索行为增强的小鼠。早期的研究表明大脑皮层神经退化
在脑损伤后,
计算机接口(BCI)探针植入年轻成年FusOLcKO小鼠。成人的终生髓鞘形成
大脑支持神经元网络的可塑性,这些可塑性是学习和维持认知健康的基础。与衰老
成人髓鞘形成的效率减弱,导致记忆力下降,在AD中,它在早期更快地失败,
病程。
这项提议旨在研究FUS依赖性髓鞘形成是否能防止神经变性,
通过维持神经网络增强神经元活性,改善衰老和AD/ADRD的记忆力
功能我们将使用定量结构和细胞分析来评估体内神经保护和动态
电生理记录以评估神经网络活动。我们将使用标准化的空间记忆测试
和适应性髓鞘形成的度量来测量髓鞘形成过度对记忆编码的影响,
在年老的FusOL cKO小鼠中的巩固。最后,我们将建立一个新的小鼠系来研究神经保护作用。
通过将FusOLcKO与
一种人性化APP、AppNG-G-F线及执行装置
初步表型和组织学表征研究。这条新线代表了未来研究的资源
并将提供给AD科学界。
在完成这些研究后,我们预计
阐明了OL和髓磷脂在衰老认知强度中的保护作用,并产生了一种新的
AD髓鞘增生小鼠模型,作为未来研究髓鞘和OL在AD中作用的资源。
英文摘要
This R03 application aims to greatly improve understanding of oligodendrocytes and myelin support in
maintaining axonal integrity, synapse and neural network function in aging and Alzheimer’s disease (AD)/AD
Related Dementias (RD). Several lines of evidence support the early role of white matter and OL loss in AD.
Imaging studies in humans show white matter changes in AD before overt cognitive decline and RNA Seq studies
demonstrated that OLs are perhaps the most substantially impacted cell-type especially early in the course of
AD. Harnessing the neuroprotective effects of OL and myelin in AD/ADRD represents a novel strategy to halt
neurodegeneration early in the course of AD/ADRD. We plan to leverage our novel hypermyelinating FusOLcKO
mice that show enhanced motor and exploratory behavior. Early studies suggest that cortical neurodegeneration
is reduced and neuronal activity is enhanced in memory encoding regions of the FusOLcKO following brain
computer interface (BCI) probe implantation in young adult FusOLcKO mice. Lifelong myelination in the adult
brain supports neuronal networks plasticity underlying learning and maintenance of cognitive health. With aging
the efficiency of adult myelination weakens leading to memory decline and in AD it fails faster and early in the
course of the disease.
This proposal aims to investigate if FUS dependent hypermyelination protects against neurodegeneration,
enhances neuronal activity and improves memory in aging and AD/ADRD by maintaining neural network
function. We will use quantitative structural and cellular analyses to assess neuroprotection and dynamic in vivo
electrophysiology recording to assess neural network activity. We will use standardized spatial memory testing
and metrics of adaptive myelination to measure the effect of hypermyelination on memory encoding and
consolidation in aged FusOL cKO mice. Finally, we will generate a new mouse line to study the neuroprotective
effect of hypermyelination in AD by crossing the FusOLcKO with the
humanized APP, AppNG-G-F line and perform
initial phenotypic and histological characterization studies. This new line represents a resource for future studies
and will be made available to the AD scientific community.
At completion of these studies, we expect to have
elucidated the protective effect of OL and myelin in cognitive strength in aging and to have generated a novel
AD hypermyelinating mouse model to serve as a resource for future studies on the role of myelin and OL in AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Oligodendrocyte Activity on Chronic Brain Implants and Recording Performance
-
批准号:10734458
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2023
-
负责人:FRANCA CAMBI
-
依托单位:
Cognitive decline in aging and AD: neuroprotection by hypermyelination in FusOLcKO
-
批准号:10549814
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2022
-
负责人:FRANCA CAMBI
-
依托单位:
Novel ALS models: FUS conditional knockout in motor neurons and oligodendrocytes
-
批准号:9026836
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:FRANCA CAMBI
-
依托单位:
Novel ALS models: FUS conditional knockout in motor neurons and oligodendrocytes
-
批准号:9210545
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7992399
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7338308
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7196200
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7912168
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7564053
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
PLP alternative splicing and oligodendrocyte differentiation
-
批准号:7743723
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2007
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:7010521
-
项目类别:
-
资助金额:$2.93万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
NEUROPROTECTION EXPLORATORY TRIALS IN PD (NET-PD)
-
批准号:8456537
-
项目类别:
-
资助金额:$5.17万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:7352797
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:7233697
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:7558546
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:8241392
-
项目类别:
-
资助金额:$10.69万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
Neuroprotection Exploratory Trials in PD (NET-PD)
-
批准号:7775041
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
CREATINE IN PARTICIPANTS WITH TREATED PARKINSON'S DISEASE
-
批准号:7607362
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2006
-
负责人:FRANCA CAMBI
-
依托单位:
PLP Splicing: In Vivo Analysis in A Mouse Model
-
批准号:6897372
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2004
-
负责人:FRANCA CAMBI
-
依托单位:
PLP Splicing: In Vivo Analysis in A Mouse Model
-
批准号:6557852
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2003
-
负责人:FRANCA CAMBI
-
依托单位:
海外基金